Home/Filings/4/0000899243-21-009155
4//SEC Filing

COOK DAVID N 4

Accession 0000899243-21-009155

CIK 0001538927other

Filed

Mar 1, 7:00 PM ET

Accepted

Mar 2, 8:29 PM ET

Size

9.0 KB

Accession

0000899243-21-009155

Insider Transaction Report

Form 4
Period: 2021-02-26
COOK DAVID N
SVP, Chief Scientific Officer
Transactions
  • Award

    Common Stock

    2021-02-26+14,30014,300 total
  • Award

    Stock Option (Right to Buy)

    2021-02-26+43,55043,550 total
    Exercise: $38.61Exp: 2031-02-25Common Stock (43,550 underlying)
  • Award

    Common Stock

    2021-02-26+5,70020,000 total
Footnotes (2)
  • [F1]These shares represented restricted stock units and will be settled into common stock upon vesting. Each restricted stock unit would be converted into one share of FMTX common stock.
  • [F2]25% of the shares subject to the stock option shall vest on February 22, 2022, and the remainder of the shares vest in equal monthly installments for a period of 36 months thereafter.

Issuer

Forma Therapeutics Holdings, Inc.

CIK 0001538927

Entity typeother

Related Parties

1
  • filerCIK 0001233684

Filing Metadata

Form type
4
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 8:29 PM ET
Size
9.0 KB